BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20218320)

  • 1. [An update of biomarkers in prostate cancer tissue].
    Wang YC; Xia SJ
    Zhonghua Nan Ke Xue; 2009 Nov; 15(11):1039-43. PubMed ID: 20218320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
    Crocitto LE; Korns D; Kretzner L; Shevchuk T; Blair SL; Wilson TG; Ramin SA; Kawachi MH; Smith SS
    Urology; 2004 Oct; 64(4):821-5. PubMed ID: 15491741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for prostate cancer.
    Makarov DV; Loeb S; Getzenberg RH; Partin AW
    Annu Rev Med; 2009; 60():139-51. PubMed ID: 18947298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging roles of DNA methylation in the clinical management of prostate cancer.
    Perry AS; Foley R; Woodson K; Lawler M
    Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].
    Yu T; Zhu SX; Zheng S; Chen SP
    Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New circulating biomarkers for prostate cancer.
    Bensalah K; Lotan Y; Karam JA; Shariat SF
    Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M; Hupertan V; Yates DR; Catto JW; Rehman I; Meuth M; Ricci S; Lacave R; Cancel-Tassin G; de la Taille A; Rozet F; Cathelineau X; Vallancien G; Hamdy FC; Cussenot O
    Clin Cancer Res; 2007 Mar; 13(6):1720-5. PubMed ID: 17363525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for prostate cancer detection.
    Reed AB; Parekh DJ
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):103-14. PubMed ID: 20014890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R; Jerónimo C
    Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
    Payne SR; Serth J; Schostak M; Kamradt J; Strauss A; Thelen P; Model F; Day JK; Liebenberg V; Morotti A; Yamamura S; Lograsso J; Sledziewski A; Semjonow A
    Prostate; 2009 Sep; 69(12):1257-69. PubMed ID: 19459176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Markers for diagnosis, prediction and prognosis of prostate cancer].
    Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV; Guo Z; Epstein JI; Sidransky D
    J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG
    Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
    Ohori M
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.
    Lee WH; Isaacs WB; Bova GS; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):443-50. PubMed ID: 9184779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
    Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
    Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other biomarkers for detecting prostate cancer.
    Nogueira L; Corradi R; Eastham JA
    BJU Int; 2010 Jan; 105(2):166-9. PubMed ID: 19930175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine markers in monitoring for prostate cancer.
    Jamaspishvili T; Kral M; Khomeriki I; Student V; Kolar Z; Bouchal J
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):12-9. PubMed ID: 19652665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.